Okava Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Okava Pharmaceuticals has a total of 17 patents globally, out of which 2 have been granted. Of these 17 patents, more than 47% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Okava Pharmaceuticals.

Okava Pharmaceuticals was founded in 2015. Okava Pharmaceuticals aims to use established drug delivery technology to repurpose approved human medications in order to take advantage of the veterinary pharmaceutical sector, which is still very underdeveloped but expanding quickly.

Do read about some of the most popular patents of Okava Pharmaceuticals which have been covered by us in this article and also you can find Okava Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Okava Pharmaceuticals patent portfolio.

How many patents does Okava Pharmaceuticals have?

Okava Pharmaceuticals has a total of 17 patents globally. These patents belong to 3 unique patent families. Out of 17 patents, 8 patents are active.

How Many Patents did Okava Pharmaceuticals File Every Year?

Okava Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOkava Pharmaceuticals Applications FiledOkava Pharmaceuticals Patents Granted
20232
20201
20192
201814

How many Okava Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Okava Pharmaceuticals Patent Portfolio

How Many Patents did Okava Pharmaceuticals File in Different Countries?

Okava Pharmaceuticals Worldwide Patent Filing

Countries in which Okava Pharmaceuticals Filed Patents

CountryPatent
Japan2
United States Of America2
Canada2
Europe2
China1
Mexico1
Korea (South)1
Australia1
Brazil1
India1
Hong Kong (S.A.R.)1

Where are Research Centers of Okava Pharmaceuticals Patents Located?

R&D Centres of Okava Pharmaceuticals

List of Okava Pharmaceuticals patents

Okava Pharmaceuticals PatentsTitle
US11786505B2Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
US11633378B2Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
EP3595639A2Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
CA3111908A1Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
CA3054817A1Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
AU2018236225A1Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
JP2020510691A5Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
HK40021867AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
EP3846798A1Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
CN110662533AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
WO2020050863A1Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
WO2018170022A3Methods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
JP2022506007AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
BR112019019003A2Methods And Compositions For Dispense Of Active Agents Of Mycophenolic Acids To Non-Human Mammals
MX2019010829AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals.
KR1020190131036AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals
IN201917041094AMethods And Compositions For Delivering Mycophenolic Acid Active Agents To Non-Human Mammals

What are Okava Pharmaceuticals key innovation segments?

What Technologies are Covered by Okava Pharmaceuticals?

The chart below distributes patents filed by Okava Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Okava Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Okava Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Okava Pharmaceuticals?

Related Articles

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Flexxon Patents – Insights & Stats (Updated 2024)

Flexxon has a total of 68 patents globally, out of which 39 have been granted. Of these 68 patents, more than 89% patents are active. Singapore is where Flexxon has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, Singaporeseems to be the main

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.